Paper55646
Regional immunotherapy of lung cancer with intrapleural B.C.G.
McKneally MF and 2 others. Lancet, 1976. Cited by 166 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regional immunotherapy of lung cancer with intrapleural B.C.G. Papers, record 55646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55646
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| BCG Vaccine | Major topic |
| Carcinoma | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Lung Neoplasms | Major topic |
| Aged | |
| Follow-Up Studies | |
| Humans | |
| Lymphatic Metastasis | |
| Neoplasm Recurrence, Local | |
| Pleura | |
| Postoperative Care | |
| Postoperative Complications | |
| Prognosis | |
| Prospective Studies | |
| Time Factors |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42437062 | BCG in the fight against cancer: exploring its applications in diverse tumour types and future directions. | Ecancermedicalscience | 2026 | https://conductscience.org/library/papers/42437062 | PubMed |
| 38693979 | Evaluation of the effects of postoperative pleural empyema on survival rates of patients after pneumonectomy due to non-small cell lung cancer. | Kardiochir Torakochirurgia Pol | 2024 | https://conductscience.org/library/papers/38693979 | PubMed |
| 36057634 | A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology. | Pilot Feasibility Stud | 2022 | https://conductscience.org/library/papers/36057634 | PubMed |
| 26175924 | Assays for predicting and monitoring responses to lung cancer immunotherapy. | Cancer Biol Med | 2015 | https://conductscience.org/library/papers/26175924 | PubMed |
| 24278806 | Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations. | Glob Adv Health Med | 2012 | https://conductscience.org/library/papers/24278806 | PubMed |
| 7466726 | Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma. | Thorax | 1980 | https://conductscience.org/library/papers/7466726 | PubMed |
| 7179188 | Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer. | Thorax | 1982 | https://conductscience.org/library/papers/7179188 | PubMed |
| 7041323 | Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma. | Thorax | 1982 | https://conductscience.org/library/papers/7041323 | PubMed |
| 7028069 | Failure of specific active immunotherapy in lung cancer. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7028069 | PubMed |
| 6966345 | Immunological approaches to cancer treatment. | Jpn J Surg | 1980 | https://conductscience.org/library/papers/6966345 | PubMed |
| 6762247 | Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6762247 | PubMed |
| 6737402 | Adjuvant therapy in colorectal cancer. | J R Soc Med | 1984 | https://conductscience.org/library/papers/6737402 | PubMed |
| 6563941 | Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6563941 | PubMed |
| 6392656 | Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin. | Jpn J Surg | 1984 | https://conductscience.org/library/papers/6392656 | PubMed |
| 6285089 | The management of lung cancer. | Lung | 1982 | https://conductscience.org/library/papers/6285089 | PubMed |
| 4036106 | Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis. | West J Med | 1985 | https://conductscience.org/library/papers/4036106 | PubMed |
| 2982882 | Small-cell lung cancer and immunochemotherapy with Propionibacterium granulosum KP 45. | J Cancer Res Clin Oncol | 1985 | https://conductscience.org/library/papers/2982882 | PubMed |
| 2938735 | Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/2938735 | PubMed |
| 2516851 | Effect of combined intrapleural administration of Lactobacillus casei (LC9018) and adriamycin on experimental malignant pleurisy in mice. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2516851 | PubMed |
| 2414458 | Update in cancer chemotherapy, Part III: Lung cancer, Part 1. | J Natl Med Assoc | 1985 | https://conductscience.org/library/papers/2414458 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/55646
GET https://conductscience.org/api/papers/v1/55646/cited_by?page=2